MANKIND PHARMA
Back to Income Statement
|
MANKIND PHARMA Last 5 Year Profit After Tax History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Profit After Tax | ₹1,941 Cr | ₹130,968 Cr | ₹1,453 Cr | ₹129 Cr | ₹10,561 Cr |
What is the latest Profit After Tax of MANKIND PHARMA ?
| Year | Profit After Tax |
|---|---|
| Mar2025 | ₹1,941 Cr |
| Mar2024 | ₹130,968 Cr |
| Mar2023 | ₹1,453 Cr |
| Mar2022 | ₹129 Cr |
| Mar2021 | ₹10,561 Cr |
How is Profit After Tax of MANKIND PHARMA Trending?
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,941 Cr | -98.52 | |
| Mar2024 | ₹130,968 Cr | 8,913.86 | |
| Mar2023 | ₹1,453 Cr | 1,023.68 | |
| Mar2022 | ₹129 Cr | -98.78 | |
| Mar2021 | ₹10,561 Cr | - | |
Compare Profit After Tax of peers of MANKIND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MANKIND PHARMA | ₹103,361.0 Cr | 1.4% | 18% | -1.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹451,075.0 Cr | 0.4% | 10.8% | 10.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,486.0 Cr | 0.7% | 9.5% | 16.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹149,124.0 Cr | -2.5% | 6% | 36.2% | Stock Analytics | |
| CIPLA | ₹115,641.0 Cr | 9.7% | 16.7% | -4.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹111,589.0 Cr | 4.5% | 9.7% | 9% | Stock Analytics | |
MANKIND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MANKIND PHARMA | 1.4% |
18% |
-1.4% |
| SENSEX | -2.7% |
-2.1% |
-5.3% |
You may also like the below Video Courses